Cold Agglutinin Disease Drugs Market is driven by Targeted Therapy Advancements
Cold agglutinin disease drugs represent a critical segment within the hematology therapeutics landscape, offering innovative solutions for patients suffering from autoimmune hemolytic anemia. These therapies include monoclonal antibodies, complement inhibitors and small molecule agents designed to interrupt the cold agglutinin–mediated destruction of red blood cells. Key advantages of...
0 Commentarii 0 Distribuiri 223 Views 0 previzualizare